Quick Takeaways
- Fred Hassan has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $9,665,530.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Fred Hassan
- Location
- Boca Raton, FL
- Summary
- The estimated net worth of Fred Hassan is at least $9,665,530 dollars as of 16 Mar 2026. Fred Hassan is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $5.89M. Fred Hassan is the Director of Cocrystal Pharma, Inc. and owns shares of Cocrystal Pharma, Inc. (COCP) stock worth about $2.92M. Fred Hassan is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $850.2K.
- Signature
- /s/ Fred Hassan, by Donald P. Lehr, as attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Fred Hassan and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: PRECIGEN, INC. ($5,892,952).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Fred Hassan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PGEN | PRECIGEN, INC. | Director | $5,892,952 | 13 Mar 2026 | ||
| COCP | Cocrystal Pharma, Inc. | Director | $2,922,384 | 09 Jan 2026 | ||
| BBIO | BridgeBio Pharma, Inc. | Director | $850,194 | 20 Jun 2025 | ||
| EYPT | EyePoint, Inc. | Director | 02 Jan 2026 | |||
| RXDX | Prometheus Biosciences, Inc. | Director | 16 Jun 2023 |
Insider Transactions Reported by Fred Hassan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.